![Baruch Harris](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Baruch Harris
Chief Operating Officer at Pretzel Therapeutics, Inc.
Network origin in Baruch Harris first degree
Entity | Entity type | Industry | |
---|---|---|---|
Pretzel Therapeutics, Inc.
![]() Pretzel Therapeutics, Inc. BiotechnologyHealth Technology Pretzel Therapeutics, Inc. is an American biotechnology company that develops therapies by utilizing mitochondrial biology. Pretzel Therapeutics is based in an undisclosed location and has research facilities in another undisclosed location. The company aims to develop treatments that address the genetic causes of mitochondrial dysfunction. The company was founded by academic experts in mitochondrial biology and is supported by a world-class investor syndicate. Jay Parrish has been the CEO of the company since 2021.
9
| Holding Company | Biotechnology | 9 |
Metera Pharmaceuticals, Inc.
![]() Metera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Metera Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Newton, MA.
2
| Private Company | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Baruch Harris via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ARCH Venture Partners LLC
![]() ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Healthcap IV GP AB
![]() Healthcap IV GP AB Financial ConglomeratesFinance Part of Odlander, Fredrikson & Co. AB, Healthcap IV GP AB is a Swedish company that provides investment services. The company is based in Sundsvall, Sweden. | Financial Conglomerates | Director/Board Member | |
Abide Therapeutics, Inc.
![]() Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Other | Consultant / Advisor | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
University of Cambridge | College/University | Graduate Degree | |
Sosei R&D Ltd.
![]() Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin | |
University College London | College/University | Undergraduate Degree | |
Instituto de Empresa SL | College/University | Masters Business Admin | |
London Business School | College/University | Masters Business Admin | |
Healthcap Annex Fund I-II GP AB | Director/Board Member | ||
Healthcap III Sidefund GP AB | Investment Managers | Director/Board Member | |
Vantia Ltd.
![]() Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Healthcap 1999 GP AB
![]() Healthcap 1999 GP AB Investment Banks/BrokersFinance Part of Odlander, Fredrikson & Co. AB, Healthcap 1999 GP AB is a company that manages and trades securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Royal College of Obstetricians & Gynaecologists | College/University | Corporate Officer/Principal | |
Mubadala Capital
![]() Mubadala Capital Investment ManagersFinance Mubadala Capital (Mubadala Capital) is a private equity subsidiary of Mubadala Investment Co. PJSC founded in 2011. The firm is headquartered in Abu Dhabi, United Arab Emirates with offices in London, New York, Rio De Janeiro, and San Francisco. | Investment Managers | Private Equity Investor | |
Novartis Venture Funds (USA)
![]() Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | Investment Managers | Corporate Officer/Principal | |
Abcodia Ltd.
![]() Abcodia Ltd. BiotechnologyHealth Technology Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
KalVista Pharmaceuticals Ltd.
![]() KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Avilex Pharma ApS
![]() Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
Congenica Ltd.
![]() Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Biotechnology | Director/Board Member | |
Cambridge Innovation Capital Ltd
![]() Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Private Equity Investor | |
Flare Capital Management Co. LLC
![]() Flare Capital Management Co. LLC Investment ManagersFinance Flare Capital Management Co LLC (Flare Capital Management) is a venture capital firm founded in 2000 by Bill Geary and Michael Greeley. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
Q-State Biosciences, Inc.
![]() Q-State Biosciences, Inc. BiotechnologyHealth Technology Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
Morphogen-IX Ltd.
![]() Morphogen-IX Ltd. Miscellaneous Commercial ServicesCommercial Services Morphogen-IX Ltd. operates as a biotechnology company. It develops bone morphogenetic proteins as a novel therapy for the treatment of Pulmonary Arterial Hypertension. The company was founded in 2015 and is headquartered in Babraham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
CMR Surgical Ltd.
![]() CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member | |
Innovaccer, Inc.
![]() Innovaccer, Inc. Packaged SoftwareTechnology Services Innovaccer, Inc. develops and delivers analytical and data science applications. The firm?s products include InCare, InNote, InGraph, InConnect and InAPI. Its solutions include ACO management, patient engagement, SDOH management, referral management, web interface reporting, PCMH, pediatric population health management and outreach management. The company was founded by Sandeep Gupta, Kanav Hasija, and Abhinav Shashank in 2014 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Founder | |
Healthcap Aero Holdings Gp | Director/Board Member | ||
Healthcap Orx Holdings Gp AB
![]() Healthcap Orx Holdings Gp AB Investment Banks/BrokersFinance Healthcap Orx Holdings Gp AB is a private company that manages securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Kip Jansson Film 1 AB
![]() Kip Jansson Film 1 AB Movies/EntertainmentConsumer Services Kip Jansson Film 1 AB produces and owns film rights. The company is headquartered in Johanneshov, Sweden. | Movies/Entertainment | Director/Board Member | |
Rspr Incentive AB | Director/Board Member | ||
Skipjack AB
![]() Skipjack AB Real Estate DevelopmentFinance Skipjack AB Manages real properties. The company is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
Upstream Research, Inc.
![]() Upstream Research, Inc. Internet Software/ServicesTechnology Services Upstream Research, Inc. operates data-driven prospecting platform. It offers upstream reports that reveal historic and present environmental risk drivers, EPA toxic release reports, available water data, and disease rates for any area. The company was founded by Nick Bedbury, John Ballantine, Scott Bedbury, and Alex Philp on August 12, 2015 and is headquartered in Bainbridge Island, WA. | Internet Software/Services | Director/Board Member | |
Healthcap Annex Fund I-Ii Bis Gp AB
![]() Healthcap Annex Fund I-Ii Bis Gp AB Financial ConglomeratesFinance Healthcap Annex Fund I-Ii Bis Gp AB operates as an investment holding Swedish company. The private company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Mubadala Ventures
![]() Mubadala Ventures Investment ManagersFinance Mubadala Ventures is a venture capital arm founded in 2017. the firm is headquartered in San Francisco, United States. the firm is a subsidiary of Mubadala Investment Co. additional offices in Abu Dhabi, New York, San Francisco, London, and Rio de Janeiro. | Investment Managers | Private Equity Investor | |
Guide Therapeutics, Inc.
![]() Guide Therapeutics, Inc. BiotechnologyHealth Technology Guide Therapeutics, Inc. develops biophotonic technology platform for the early detection of disease that leads to cancer. The company was founded by James Dahlman and Cory Sago and is headquartered in Tucker, GA. | Biotechnology | Director/Board Member | |
Cantando Holding AB | Director/Board Member | ||
Xilis, Inc.
![]() Xilis, Inc. Medical SpecialtiesHealth Technology Xilis, Inc. engages in the development of droplet-based microfluidics technology devices for precision cancer diagnostics and drug development. It offers Xilis platform. The company was founded by Xiling Shen and David Shu and is headquartered in Durham, NC. | Medical Specialties | Director/Board Member | |
Rome Therapeutics, Inc.
![]() Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder | |
Wellpay Corp.
![]() Wellpay Corp. Packaged SoftwareTechnology Services Wellpay Corp. operates a financial technology platform. The firm offers secure payment and financing solutions for all healthcare practice types. The company was founded by Mohammad Gaber, Noha Carrington and Jonathan Eng in February 2019 and is headquartered in San Mateo, CA. | Packaged Software | Director/Board Member | |
Alloy Therapeutics LLC
![]() Alloy Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Argobio SAS
![]() Argobio SAS Miscellaneous Commercial ServicesCommercial Services Argobio SAS is a start-up studio founded in 2021 and based in Paris, FR. The company was initiated by Kurma Partners, a leading healthcare venture capital firm based in France, and Bpifrance, the French national investment bank. The French company aims to nurture and launch at least five breakthrough biotech companies over the next five years by sourcing innovative early-stage projects from renowned European academic research institutions. The focus is on selected therapeutic areas, including rare diseases, neurological disorders, oncology, and immunology. Argobio will identify, select, and incubate these projects up to company creation and beyond, providing broad expertise in the discovery and development of novel drugs with a team of highly experienced biotech entrepreneurs. The internal team is led by Yves Ribeill, Neill Mackenzie, Poul Sørensen, and Rémi Soula. Thierry Laugel, Managing Partner at Partners, is the President of Argobio. Kurma and Bpifrance were joined by complementary strategic investors, Angelini Pharma, a private international pharmaceutical company, Evotec, a drug discovery alliance and development partnership company, and the Institut Pasteur, an internationally renowned center for biomedical research. | Miscellaneous Commercial Services | Director/Board Member | |
NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ariceum Therapeutics GmbH
![]() Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Angelini Ventures SpA
![]() Angelini Ventures SpA Investment ManagersFinance Angelini Ventures SpA (Angelini Ventures) is a venture capital firm founded in 2022. The firm is headquartered in Rome, Italy. | Investment Managers | Chief Executive Officer | |
Orbital Therapeutics, Inc.
![]() Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Biotechnology | Founder Consultant / Advisor | |
University of Jordan | College/University | Undergraduate Degree | |
ELTEC Elektronik AG
![]() ELTEC Elektronik AG Computer PeripheralsElectronic Technology ELTEC Elektronik AG engages in the provision of digital network and wireless communications solutions for railway and automotive applications. It designs and produces wifi access points; routers and gateways; data loggers; ethernet switches; and I/O (input/output) modules.The company was founded on December 17, 1999 and is headquartered in Mainz, Germany. | Computer Peripherals | Director/Board Member | |
Inivata Ltd.
![]() Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Packaged Software | Director/Board Member |
Statistics
International
United States | 19 |
United Kingdom | 14 |
Sweden | 12 |
Germany | 3 |
Spain | 2 |
Sectoral
Health Technology | 15 |
Finance | 14 |
Consumer Services | 10 |
Commercial Services | 6 |
Technology Services | 5 |
Operational
Director/Board Member | 85 |
Independent Dir/Board Member | 15 |
Corporate Officer/Principal | 12 |
Founder | 7 |
Private Equity Investor | 6 |
Most connected contacts
Insiders | |
---|---|
Kristina Burow | 40 |
Per Anders Göte Samuelsson | 36 |
Robert Tansley | 18 |
Alaa Halawa | 12 |
Jay Parrish | 11 |
Paolo Di Giorgio | 8 |
Avrum Spira | 1 |
Vijay Murthy | 1 |
Gabriel Martinez | 1 |
Maria Falkenberg | 1 |
Reetika Bhardwa | 1 |
- Stock Market
- Insiders
- Baruch Harris
- Company connections